Revive Pro Care (AXIL): Total Asset Value of Company

AXIL Brands, Inc. (AXIL) relies on US plants featuring automated mixing and strict temperature-controlled storage. The holding's growth is driven by multi-channel distribution and the high demand for hearing and skin protection products. This chart illustrates total assets, which currently stand at 16.99. Stable demand for biotechnology makes the business a defensive asset, independent of global economic fluctuations.

AXIL Brands (AXIL) Company Total Assets: for the period 02/21/2024 - 10/28/2026

Comprehensive metric breakdowns and analytics for reviveprocare.com (AXIL)

- price and consensus price forecast:

Price Chart AXIL Brands|AXIL - Price Target Chart

- market capitalization data:

Market Valuation Revive Pro Care|AXIL - Enterprise Value

- book capitalization data:

Accounting Value of a Share AXIL Brands|AXIL - Book Capitalization|Market Capitalization to Book Value Ratio reviveprocare.com|AXIL - Aggregate Company Assets

- debt and liquidity data:

All Debt to Shareholders' Equity Ratio AXIL Brands, Inc.|AXIL - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio AXIL Brands|AXIL - Company Aggregate Debts|Debts to Book Capitalization Revive Pro Care

Fundamental valuation:AXIL, Revive Pro Care

A conservative investor assesses the stability of AXIL Brands, Inc. (AXIL) through the dynamics of total assets and liabilities, reverse-calculated based on return on assets (ROA). By analyzing the growth of assets and resources, one can determine the extent to which an organic portfolio reimagining and a shift away from mergers in favor of marketing collaborations optimize the balance sheet structure, which is critical for evaluating the company's operational efficiency and investment profile.

Competitors of AXIL Brands, Inc. (AXIL)

KRYS (krystalbio.com) - Aggregate Company Assets|Aggregate Company Assets Apogee Therapeutics, Inc. APGE|Total Asset Value of Company Arcutis|Vericel Corp. (VCEL) - Company Total Assets|Aggregate Asset Value Oruka Pharma (ORKA)|Company Total Assets SMTI (Sanara MedTech)|DBV Tech - Company Total Assets|Aggregate Company Assets Solesence Inc. (SLSN)|DERM: Aggregate Asset Value|FBRX (Forte Biosciences, Inc) - Aggregate Company Assets|Empro Corporation (EMPG) - Cumulative Company Assets|SLGL (Sol-Gel Technologies) - Company Total Assets|Company Total Assets medicuspharma.com (MDCX)|Verrica Pharmaceuticals (VRCA) - Cumulative Company Assets|Aggregate Asset Value HOTH (hoththerapeutics.com)|Aggregate Company Assets BFRI|VYNE Therapeutics, Inc. - Company Total Asset Base|Sonoma Pharma - Aggregate Company Assets|QNRX - Company Total Assets|Azitra - Company Total Assets|DRMA (Dermata Therapeutics Inc) - Company Total Asset Base|Aggregate Company Assets Elevai Skincare (ELAB)|Total Business Assets Revance Therapeutics Inc